NCT06109779 2026-03-04Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)AstraZenecaPhase 3 Active not recruiting757 enrolled
NCT06282575 2026-02-24Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerJazz PharmaceuticalsPhase 3 Recruiting286 enrolled
NCT04003636 2025-04-23KEYNOTE-966Merck Sharp & Dohme LLCPhase 3 Completed1,069 enrolled 19 charts 1 FDA
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts